Yamanaka factors
Yamanaka factors Yamanaka factors – four factors that could changing aging research, our biological age and life itself. The Yamanaka …
The quest for rejuvenation without reprogramming
Clock.bio founders on how a cocktail of existing drugs may hold the key to restoring all the hallmarks of aging. …
Continue reading “The quest for rejuvenation without reprogramming”
Rejuvenation Technologies exits stealth with $10.6m for age-reversing mRNA therapeutics
Khosla Ventures leads seed round for longevity biotech startup targeting telomere attrition. Longevity biotech Rejuvenation Technologies has emerged from …
Longevity investment bulletin: CARMAT, LifeX Ventures, Fractyl and more
The latest longevity updates from our investment news desk. CARMAT lands €13.2m funding Artificial heart developer CARMAT announced it has …
Continue reading “Longevity investment bulletin: CARMAT, LifeX Ventures, Fractyl and more”
Life Biosciences presents data demonstrating restoration of visual function in nonhuman primates
Data in a nonhuman primate model of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) demonstrates the ability to restore visual function …
Is aging driven by flaws in our software?
New paper hypothesizes aging to be a result of intrinsic flaws in the software. Aging occurs due to the accumulation …
Continue reading “Is aging driven by flaws in our software?”
Retro: A longevity biotech triple-threat?
Joe Betts-LaCroix on investing in longevity biotech and Retro’s progress in cellular reprogramming, autophagy and plasma programs. When longevity-focused decentralized …
Continue reading “Retro: A longevity biotech triple-threat?”
Where’s the longevity funding going?
From cellular reprogramming to regeneration, more than 80% of funding in 2022 was focused on five key longevity domains. One …
Impact of changes in the epigenome on aging
If changes to the epigenome drive the aging process, might epigenetic manipulation throw things into reverse gear? Aging is a …
Continue reading “Impact of changes in the epigenome on aging”
